| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Irina Kerkis | |
| Celine Pompeia | |||
| Cristiane Valverde Wenceslau | |||
| Mônica Santoro Haddad | |||
| P2860 | cites work | Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient | Q21090134 |
| Towards a transgenic model of Huntington's disease in a non-human primate | Q24644013 | ||
| Neural and mesenchymal stem cells in animal models of Huntington's disease: past experiences and future challenges | Q26775932 | ||
| Mesenchymal stem cells: immune evasive, not immune privileged | Q27003371 | ||
| A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. | Q27860836 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Embryonic stem cell lines derived from human blastocysts | Q27861010 | ||
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| An overview of mammalian pluripotency | Q28067522 | ||
| Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease | Q28202050 | ||
| Huntington's disease | Q28365461 | ||
| Molecular regulation of vessel maturation | Q29614540 | ||
| Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice | Q29615357 | ||
| Mesenchymal stem cells | Q29619804 | ||
| Mesenchymal stem cells as trophic mediators | Q29619806 | ||
| Effects of neural progenitor cells on post-stroke neurological impairment-a detailed and comprehensive analysis of behavioral tests | Q30594942 | ||
| Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington's disease. | Q31033640 | ||
| Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients | Q31115405 | ||
| Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington's disease | Q33533774 | ||
| Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial | Q33592708 | ||
| In Vivo Roles of a Patient-Derived Induced Pluripotent Stem Cell Line (HD72-iPSC) in the YAC128 Model of Huntington's Disease. | Q33727646 | ||
| Huntington's disease: from molecular pathogenesis to clinical treatment | Q33773061 | ||
| An ovine transgenic Huntington's disease model | Q33815561 | ||
| Transplantation of induced pluripotent stem cells improves functional recovery in Huntington's disease rat model | Q33939904 | ||
| Brain-derived neurotrophic factor in neurodegenerative diseases | Q34017880 | ||
| BDNF signaling and survival of striatal neurons | Q34102098 | ||
| MR spectroscopic studies of the brain in psychiatric disorders | Q34147260 | ||
| Expression of Huntington's disease protein results in apoptotic neurons in the brains of cloned transgenic pigs | Q34163091 | ||
| PET imaging shows loss of striatal PDE10A in patients with Huntington disease | Q45296605 | ||
| Intravenous administration of human neural stem cells induces functional recovery in Huntington's disease rat model | Q45296899 | ||
| Susceptibility-weighted imaging changes suggesting brain iron accumulation in Huntington's disease: an epiphenomenon which causes diagnostic difficulty | Q45297881 | ||
| Technical factors that influence neural transplant safety in Huntington's disease. | Q45299664 | ||
| Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's disease. | Q45300235 | ||
| Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes | Q45300522 | ||
| Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease. | Q45300810 | ||
| Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease | Q45302681 | ||
| Bilateral human fetal striatal transplantation in Huntington's disease. | Q45305502 | ||
| Juvenile Huntington disease: CT and MR features. | Q45307137 | ||
| Stem cell factor and mesenchymal and neural stem cell transplantation in a rat model of Huntington's disease | Q45307234 | ||
| Progenitor cells of the olfactory receptor neuron lineage | Q46695680 | ||
| Embryonic stem cells stably expressing BDNF-GFP exhibit a BDNF-release-dependent enhancement of neuronal differentiation | Q47678397 | ||
| Comparing brain-derived neurotrophic factor and ciliary neurotrophic factor secretion of induced neurotrophic factor secreting cells from human adipose and bone marrow-derived stem cells | Q47780514 | ||
| Reprogramming of human fibroblasts to pluripotency with lineage specifiers | Q47972886 | ||
| Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. | Q48365871 | ||
| Huntington disease | Q48465200 | ||
| Anterograde transport of brain-derived neurotrophic factor and its role in the brain | Q48539947 | ||
| The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. | Q51791870 | ||
| Dementia and movement disorders | Q80486364 | ||
| [BDNF secretion in human mesenchymal stem cells isolated from bone marrow, endometrium and adipose tissue] | Q86292590 | ||
| Biochemical, histopathological and behavioral alterations caused by intrastriatal administration of quinolic acid to young rats | Q87418502 | ||
| Glutamate transporters in neurologic disease | Q34187611 | ||
| Animal models of Huntington's disease | Q34665829 | ||
| Neural stem cells: balancing self-renewal with differentiation | Q34763775 | ||
| Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. | Q35030040 | ||
| Adult stem cells for tissue repair - a new therapeutic concept? | Q35194623 | ||
| Stem cell technology for neurodegenerative diseases. | Q35224202 | ||
| Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology | Q35579484 | ||
| Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics | Q36249852 | ||
| Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells | Q36423519 | ||
| Equine-Induced Pluripotent Stem Cells Retain Lineage Commitment Toward Myogenic and Chondrogenic Fates | Q36480691 | ||
| Role of brain-derived neurotrophic factor in Huntington's disease | Q36767260 | ||
| Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. | Q36954944 | ||
| Mesenchymal stem cells: revisiting history, concepts, and assays. | Q37036368 | ||
| The psychopathology of Huntington's disease | Q37079566 | ||
| A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions | Q37178480 | ||
| Progress in restorative neurosurgery: human fetal striatal transplantation in Huntington's disease. Review. | Q37971315 | ||
| A systematic review of the intergenerational aspects and the diverse genetic profiles of Huntington's disease | Q38126446 | ||
| Choosing an animal model for the study of Huntington's disease | Q38139868 | ||
| Mesenchymal stromal cells: sensors and switchers of inflammation | Q38149359 | ||
| Neural stem cells: generating and regenerating the brain | Q38158714 | ||
| One million haemopoietic stem-cell transplants: a retrospective observational study | Q38384271 | ||
| Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells | Q38462208 | ||
| A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration. | Q38779102 | ||
| Feeder-free derivation of induced pluripotent stem cells from human immature dental pulp stem cells | Q39764925 | ||
| Slowed progression in models of Huntington disease by adipose stem cell transplantation | Q39770706 | ||
| Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases. | Q39825184 | ||
| Human embryonic stem cell-derived neural precursor transplants attenuate apomorphine-induced rotational behavior in rats with unilateral quinolinic acid lesions | Q40099462 | ||
| Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease | Q40543499 | ||
| Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury | Q40643190 | ||
| Embryonic stem cell-derived glial precursors: a source of myelinating transplants | Q40938819 | ||
| Human neural stem cell transplants improve motor function in a rat model of Huntington's disease | Q42463574 | ||
| fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease. | Q42471124 | ||
| Comparison of transplant efficiency between spontaneously derived and noggin-primed human embryonic stem cell neural precursors in the quinolinic acid rat model of Huntington's disease | Q43115809 | ||
| Mitochondrial calcium, oxidative stress and apoptosis in a neurodegenerative disease model induced by 3-nitropropionic acid | Q44792354 | ||
| Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model | Q45178238 | ||
| Neuroprotective effects and magnetic resonance imaging of mesenchymal stem cells labeled with SPION in a rat model of Huntington's disease | Q45289124 | ||
| Development of human striatal anlagen after transplantation in a patient with Huntington's disease | Q45289953 | ||
| Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation | Q45292873 | ||
| Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. | Q45293425 | ||
| Neuropsychological functioning following fetal striatal transplantation in Huntington's chorea: three case presentations | Q45294365 | ||
| Safety of intrastriatal neurotransplantation for Huntington's disease patients | Q45295583 | ||
| P433 | issue | 4 | |
| P921 | main subject | Huntington's disease | Q190564 |
| P304 | page(s) | 287-295 | |
| P577 | publication date | 2016-10-01 | |
| P1433 | published in | Dementia & neuropsychologia | Q27725091 |
| P1476 | title | Cell-based technologies for Huntington's disease | |
| P478 | volume | 10 |
Search more.